Yosu Luque

1.2k total citations
44 papers, 384 citations indexed

About

Yosu Luque is a scholar working on Nephrology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yosu Luque has authored 44 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Nephrology, 11 papers in Immunology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yosu Luque's work include Renal Diseases and Glomerulopathies (9 papers), Complement system in diseases (9 papers) and Renal Transplantation Outcomes and Treatments (7 papers). Yosu Luque is often cited by papers focused on Renal Diseases and Glomerulopathies (9 papers), Complement system in diseases (9 papers) and Renal Transplantation Outcomes and Treatments (7 papers). Yosu Luque collaborates with scholars based in France, United States and Spain. Yosu Luque's co-authors include Laurent Mesnard, Éric Rondeau, Sophie Vandermeersch, Sandrine Placier, Marie‐Christine Verpont, Chantal Jouanneau, Alexandre Hertig, Michel Daudon, Emmanuel Letavernier and Emmanuel Estève and has published in prestigious journals such as Blood, The Journal of Immunology and PLoS ONE.

In The Last Decade

Yosu Luque

41 papers receiving 379 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yosu Luque France 10 161 76 66 60 60 44 384
Maren Burbach France 7 81 0.5× 41 0.5× 39 0.6× 19 0.3× 59 1.0× 7 236
Teresa Olea Spain 9 303 1.9× 65 0.9× 10 0.2× 78 1.3× 41 0.7× 19 547
Anne‐Sophie Garnier France 10 91 0.6× 12 0.2× 51 0.8× 92 1.5× 59 1.0× 21 295
Nicole J. Krumrei United States 8 97 0.6× 18 0.2× 40 0.6× 32 0.5× 199 3.3× 12 527
Roberto Giacosa Italy 11 143 0.9× 79 1.0× 44 0.7× 128 2.1× 38 0.6× 15 401
Abubakr Imam United States 11 149 0.9× 23 0.3× 10 0.2× 70 1.2× 32 0.5× 25 331
Aurélie Grandvuillemin France 12 23 0.1× 44 0.6× 48 0.7× 53 0.9× 63 1.1× 33 346
Christopher Clardy United States 10 61 0.4× 20 0.3× 29 0.4× 42 0.7× 91 1.5× 17 405
Tomoko Takano Japan 13 144 0.9× 26 0.3× 68 1.0× 40 0.7× 68 1.1× 38 548
F. Martinez France 9 116 0.7× 15 0.2× 33 0.5× 57 0.9× 16 0.3× 15 328

Countries citing papers authored by Yosu Luque

Since Specialization
Citations

This map shows the geographic impact of Yosu Luque's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yosu Luque with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yosu Luque more than expected).

Fields of papers citing papers by Yosu Luque

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yosu Luque. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yosu Luque. The network helps show where Yosu Luque may publish in the future.

Co-authorship network of co-authors of Yosu Luque

This figure shows the co-authorship network connecting the top 25 collaborators of Yosu Luque. A scholar is included among the top collaborators of Yosu Luque based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yosu Luque. Yosu Luque is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dixon, Bradley P., David Kavanagh, Brigitte Adams, et al.. (2024). Ravulizumab in Atypical Hemolytic Uremic Syndrome: An Analysis of 2-Year Efficacy and Safety Outcomes in 2 Phase 3 Trials. Kidney Medicine. 6(8). 100855–100855. 8 indexed citations
2.
Montagud‐Marrahí, Enrique, Yosu Luque, Tarek Ajami, et al.. (2024). Ex vivo normothermic preservation of a kidney graft from uncontrolled donation after circulatory death over 73 hours. Frontiers in Bioengineering and Biotechnology. 11. 1330043–1330043. 2 indexed citations
3.
Lanot, Antoine, Yosu Luque, Bénédicte Sautenet, et al.. (2024). Simulation-based learning in nephrology. Clinical Kidney Journal. 17(4). sfae059–sfae059. 3 indexed citations
4.
Bureau, Côme, Cédric Rafat, Jean‐Luc Taupin, et al.. (2023). Immunoadsorption-Based HLA Desensitization in Patients Awaiting Deceased Donor Kidney Transplantation: An Interventional, Non-Randomised, Single Cohort Study. Transplant International. 36. 11212–11212. 4 indexed citations
5.
Morel, Antoine, Marie Matignon, Philippe Grimbert, et al.. (2023). Hepatitis B Virus Reactivation in Kidney Transplant Recipients Treated With Belatacept. Kidney International Reports. 8(8). 1531–1541. 4 indexed citations
6.
7.
Chung, Hyunjae, Takanori Komada, Arthur Lau, et al.. (2021). AIM2 Suppresses Inflammation and Epithelial Cell Proliferation during Glomerulonephritis. The Journal of Immunology. 207(11). 2799–2812. 11 indexed citations
8.
Luque, Yosu, et al.. (2021). Vancomycin-Associated Tubular Casts and Vancomycin Nephrotoxicity. Kidney International Reports. 6(7). 1912–1922. 26 indexed citations
9.
Michel, P.A., Éric Daugas, Hafedh Fessi, et al.. (2021). Management of Undocumented Immigrants With End-Stage Kidney Disease in 2 Academic Hospitals in Paris. Kidney International Reports. 7(3). 610–613. 1 indexed citations
10.
Belenfant, Xavier, Ziad A. Massy, Emmanuelle Corruble, et al.. (2021). Can empathy be taught? A cross-sectional survey assessing training to deliver the diagnosis of end stage renal disease. PLoS ONE. 16(9). e0249956–e0249956. 4 indexed citations
11.
Rafat, Cédric, Emmanuel Letavernier, Vincent Frochot, et al.. (2020). Acute Kidney Injury After High Doses of Amoxicillin. Kidney International Reports. 6(3). 830–834. 8 indexed citations
12.
Luque, Yosu, Patricia Senet, Patricia Mariani, et al.. (2020). Ockham’s razor defeated: about two atypical cases of hemolytic uremic syndrome. BMC Nephrology. 21(1). 269–269. 4 indexed citations
13.
Luque, Yosu, et al.. (2020). Penile Calciphylaxis. Urology. 140. e8–e9. 3 indexed citations
14.
Luque, Yosu, et al.. (2019). Vancomycin nephrotoxicity: Vancomycin tubular casts with characteristic electron microscopic findings. PubMed. 7(1). 66–72. 10 indexed citations
15.
Luque, Yosu & Laurent Mesnard. (2018). Néphrotoxicité de la vancomycine : fréquence et mécanismes. Néphrologie & Thérapeutique. 14. S133–S138. 7 indexed citations
16.
Luque, Yosu, Olivia Lenoir, Philippe Bonnin, et al.. (2017). Endothelial Epas1 Deficiency Is Sufficient To Promote Parietal Epithelial Cell Activation and FSGS in Experimental Hypertension. Journal of the American Society of Nephrology. 28(12). 3563–3578. 18 indexed citations
17.
Luque, Yosu, Dominique Cathelin, Sophie Vandermeersch, et al.. (2017). Glomerular common gamma chain confers B- and T-cell–independent protection against glomerulonephritis. Kidney International. 91(5). 1146–1158. 8 indexed citations
18.
Weiss, Nicolas, Franck Verdonk, Loïc Le Guennec, et al.. (2015). Daily FOUR score assessment provides accurate prognosis of long-term outcome in out-of-hospital cardiac arrest. Revue Neurologique. 171(5). 437–444. 13 indexed citations
19.
Mesnard, Laurent, Dominique Cathelin, Sophie Vandermeersch, et al.. (2014). Genetic Background–Dependent Thrombotic Microangiopathy Is Related to Vascular Endothelial Growth Factor Receptor 2 Signaling during Anti-Glomerular Basement Membrane Glomerulonephritis in Mice. American Journal Of Pathology. 184(9). 2438–2449. 9 indexed citations
20.
Cathelin, Dominique, Sandrine Placier, Michael Ploug, et al.. (2014). Administration of Recombinant Soluble Urokinase Receptor Per Se Is Not Sufficient to Induce Podocyte Alterations and Proteinuria in Mice. Journal of the American Society of Nephrology. 25(8). 1662–1668. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maren Burbach Breakdown of academic impact, for papers by Teresa Olea Breakdown of academic impact, for papers by Anne‐Sophie Garnier Breakdown of academic impact, for papers by Nicole J. Krumrei Breakdown of academic impact, for papers by Roberto Giacosa Breakdown of academic impact, for papers by Abubakr Imam Breakdown of academic impact, for papers by Aurélie Grandvuillemin Breakdown of academic impact, for papers by Christopher Clardy Breakdown of academic impact, for papers by Tomoko Takano Breakdown of academic impact, for papers by F. Martinez
Rankless by CCL
2026